Harald O. Schöcklmann

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

Jan Menne, Martin Nitschke, Robert Stingele et al. · BMJ · 2012 · 306 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +9

α8 Integrin in glomerular mesangial cells and in experimental glomerulonephritis

Andrea Hartner, Harald O. Schöcklmann, Felicitas Pröls et al. · Kidney International · 1999 · 88 citations · Full text

Medicine, Nephrology, Pathology +14

Duration of Fecal Shedding of Shiga Toxin–Producing Escherichia coli O104:H4 in Patients Infected During the 2011 Outbreak in Germany: A Multicenter Study

R.-P. Vonberg, Michael Höhle, Martin Aepfelbacher et al. · Clinical Infectious Diseases · 2013 · 48 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy

Katja Haemmerli Keller, Christoph Daniel, Harald O. Schöcklmann et al. · Nephrology Dialysis Transplantation · 2006 · 38 citations · Full text

Medicine, Nephrology, Pathology +17

Dynamic expression patterns of transforming growth factor-β2 and transforming growth factor-β receptors in experimental glomerulonephritis

Andrea Hartner, Karl F. Hilgers, Markus Bitzer et al. · Journal of Molecular Medicine · 2002 · 33 citations

Medicine, Molecular Biology, Nephrology +16